29 September (Thursday)

830am to 9am

Resilient Leadership and the Role of Well-Being in the Healthcare Environment (P)

In this podcast, QSHRM will be joined by Laurie Baedke (https://www.lauriebaedke.com), Director of Healthcare Leadership Programs at Creighton University. Laurie will talk about resiliency, resilient leaders, and the habits of high-performing executives.

Note: This is a pre-summit podcast, there will be no moving pictures or slides. The general aim is to listen to it as you were listening to a radio program

9am to 930am

Opening and Welcome Address (L)

Dr. Salih Ali A A Almarri Assistant Minister Ministry of Public Health | State of Qatar

Dr. Moza Alishaq QSHRM 2022 Chairperson and Executive Director Clinical Transformation | HMC

Introduction of Speakers:
Ms. Fatemaah Narooei | Project Manager | Corporate QPS/HMC

930am to 1030am

The role of risk management in corporate resilience (W)

What does resilience mean to you and your organization? How are risk managers involved in corporate resilience and how will this evolve? FERMA (Federation of European Risk Manager Association) and McKinsey will present the findings of our survey into resilience and risk management. The objective is to give risk and insurance professionals a richer understanding of resilience in a strategic and practical way. Two leading risk managers will discuss the results of our survey and will reflect more broadly on the link between risk and resilience. By the end of the webinar, you will be well versed in resilience from an enterprise risk management perspective.

Learning Objective:

  • This session will discuss key findings of FERMA’s survey on resilience for risk and insurance managers

Speakers:

1. Dr. Ulrich Adamheit | Head of Business Risk, CFO Functions, Risk Management | Vattenfall AB

2. Mr. Francois Malan | Chief Risk and Compliance Officer | Eiffage

3. Mr. Alfonso Natale | Partner at McKinsey & Company

Note: This is a pre-recorded webinar, there will be no live forum or Q&A after the session.

1030am to 1130am

Understanding the correlation between Risk Identification and Patient Safety Culture (L)

Learning Objective:

  • Explore the existing situation on risk identification and its relationship with safety culture
  • Understand methods how to gauge current risk practices and its relativity to safety culture

Speaker:
Dr. Yasmine Salim Abdullah Al Hatimy, Ph.D. (Med) MA HMPP (Quality) | Deputy Director, Quality & Development Directorate

Sr. Quality Specialist (A) in Quality & Healthcare Accreditation | Sultan Qaboos University Hospital Muscat, Sultanate of Oman

Moderator:
Ms. Muna Abdel Hakim R Atrash | Senior Quality Improvement Reviewer | Al Wakrah Hospital/HMC

1130am to 1215pm

Prayer Time/Stretch and Movement Break

1215pm to 115pm

Resilient Leadership: Part of a Trust and Care System (L)

Healthcare remains a high-risk environment despite medical and technological developments. We can expect to encounter potential harm and the need to recover from adverse events. Commitment to Resilience is one recognised principle in striving for high-reliability in high-risk environments.

Leadership defines the culture of our workplaces and whether we will be resilient. Trust and care create our systems, our leaders, our resilience. Without trust, leadership, and resilience, are we able to care for our staff and patients?

Learning Objectives:

  • Demonstrate that trust and care are requirements to lead resiliently.
  • Trust and care appear in many forms in our organisations.
  • 3 Leadership is part of a resilient system.

Speaker:
Dr. James Laughton Group Head for Risk, Quality and Patient Safety HMC Ambulance Service 

Moderator:
Mr. John Paul Serillano Cruz | Hospital Compliance Coordinator | Hamad Dental Center

115pm to 215pm

Importance of Leadership role in healthcare staff motivation during challenging times (L)

The topic will address how leadership role can help to improve staff morale and motivation specially during challenging times and it can impact provision of safe and high-quality patient care.

Learning Objectives:

  • Discuss the importance of leadership role in staff engagement and motivation and how it builds a leadership culture
  • Review the impact of staff satisfaction and joy at work on provision of safe care

Speaker:
Dr. Faiza Shaukat Shahzad Malik Assistant Executive Director Quality and Patient Safety Qatar Rehabilitation Institute

Moderator:
Ms. Jennifer Suganob Lagunday | Senior Quality Improvement Reviewer | QRI/HMC

215pm to 315pm

Strategies to improve patient safety and reduce risks: Nurse Leader Role (L)

Learning Objectives:

  • Discuss the role of nurse leader in achieving high reliability organization.
  • Discuss strategies the nurse leader may implement to improve patient safety and reduce risks in the clinical areas.

Speaker:
Mr. Thabit Melhem, Executive Director Corporate Nursing and Midwifery | HMC

Moderator:

Mr. Glenn Tamayo Ocampo | Quality & Patient Safety Coordinator | HMGH/HMC

315pm to 415pm

How to investigate a medical misconduct (L)

Learning Objective:

  • Understand the nature of errors and how healthcare providers can learn from errors to improve patient safety

Speaker:
Rashid Al-Abri, MD, FRCS. Professor & Sr. Consultant ENT | Sultan Qaboos University Muscat Oman

Moderator:
Mr. Oliver David Velasco Dulman | Quality Management/Improvement Reviewer | HMGH/HMC

415pm to 515pm

Grow Your Own: Developing Risk Management Talent in Your Organization (L)

The Risk Manager is not a Risk Magician. You cannot do it all. Because of this, Risk Managers may feel like they are missing budding risk exposures. How does the organizational Risk Manager build a team of risk-savvy, risk-minded individuals who can serve as their eyes and ears, creating a web throughout the organization? This session will provide the rationale, strategies, and impetus to help the risk manager grow their informal risk management team. Who knows? Future risk managers are lurking right in front of you!

Learning Objectives:

  • Discuss the need for expanding risk management focus across the organization
  • Describe methods to identify and develop raw risk management talent
  • Outline benefits of developing a broadened risk management base

Speakers:

1. Kathryn Schaefer, MSN, RN, CPHRM, CHCP, FASHRM | Associate Director, Education Quality and Compliance | Med-IQ

2. Geri Amore, MSN, RN, CPHRM, CHCP, FASHRM | Principle | Amori Associates

Moderator:
Mr. Roderick Batang Dayag | Head of Quality Improvement | ACC/HMC

515pm to 615pm

Opening Keynote Address: Ms. Barbara McCarty, ASHRM President

Introduction:
Dr. Moza Alishaq | QSHRM 2022 Chairperson

615pm to 715pm

Everything Changes – Keeping Up with Risk Financing Trends (L)

This session educates attendees on the changing risk financing landscape, and how these new factors are impacting everything from risk philosophies to structure and renewal strategies. Addressed factors include social inflation, market changes, exposure changes and more, all which impact retention levels, decisions on insourcing/outsourcing expertise, and the total cost of risk.

Learning Objectives:

  • Identify four factors impacting the insurance landscape;
  • Review case studies showing program adaptions to market changes
  • Utilize factor identification to create renewal strategies

Speaker:

1. Pamela Poop, MA JD DFASHRM CPHRM AIM | Chief Risk Officer & Executive Vice President | GB Healthcare

2. Elizabeth Huntington, MSN JD | Chief Risk Officer | Baptist Health

Moderator:
Mr. Roderick Batang Dayag | Head of Quality Improvement | ACC/HMC

715pm to 815pm

Waning Vaccine, Natural and Hybrid Immunity – Covid19 vs World Cup

Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) provides natural immunity against reinfection. Recent studies have shown waning of the immunity provided by vaccines. The time course of natural and hybrid immunity is unknown. This session will discuss issues, concerns and recent studies related to waning vaccine, natural and hybrid immunity and how this could affect big sporting events such as the World Cup.

Learning Objectives:

  • Understand ongoing mutations and variants of Covid-19
  • Understand vaccine effectiveness and waning of vaccine efficacy
  • Learn the concept of hybrid immunity
  • Understand usage of rapid tests, antivirals, and risk management

Speaker:
Dr. Andrew Jeremijenko | Group Medical Director of Aspen Medical | Brisbane, Australia

Moderator: 
Dr. Mark Dimon Santos | Clinical Nurse/Midwife Specialist | HMGH/HMC

815pm to 830pm

Day 1 Wrap Up and announcement of Day 2 sessions